HCC is the predominant malignancy in the liver and recent evidence shows a role for SIRT1/PGC-1alpha/mitochondrial biosynthesis pathway in protecting the liver against lipid accumulation and mitochondrial dysfunction (61, 62). The gene discussed is SIRT1; the disease is hepatocellular carcinoma.